|6.64||-0.465 / -6.55%|
Data as of 3:59pm ET
|6.63||-0.0008 / -0.01%|
The 8 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 11.25, with a high estimate of 26.00 and a low estimate of 6.00. The median estimate represents a +69.56% increase from the last price of 6.64.
The current consensus among 9 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.